Feng Du

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feng Du

Quick Facts: Naloxone Hydrochloride

Property Description
Active ingredient Naloxone Hydrochloride
Form Injectable Solution, Nasal Spray, Auto-injector
Pharmacological class Opioid Antagonist / Narcotic Antagonist
Common purpose Emergency reversal of opioid effects
Origin Synthetic morphinane alkaloid derivative

What is Feng Du? Defining the Critical Opioid Antagonist

The medication known as Feng Du, which contains the active ingredient Naloxone Hydrochloride, is a critical pharmaceutical agent used exclusively for immediate emergency intervention. Pharmacologically, it is classified as a fast-acting Opioid Antagonist, a type of drug that specifically counters and blocks the depressant effects of opioids in the body. Naloxone is clinically recognized for its essential role in addressing the global public health concern of opioid-induced respiratory depression. As a synthetic derivative of the morphinane alkaloid structure, its development represents a targeted chemical countermeasure to the widespread effects of opioid substances.

Composition and Accessible Forms of Naloxone

Naloxone Hydrochloride is formulated as a single-ingredient product, typically prepared within a sterile aqueous solution base. The drug’s distinctive feature lies in its optimization for rapid administration in non-hospital settings. It is widely available in diverse dosage forms, including prepackaged injectable solutions for swift delivery via the intramuscular (IM) route, and the user-friendly nasal spray for non-invasive intranasal use. Naloxone is categorized as an essential medicine, confirming the drug’s indispensability and flexibility as an accessible emergency therapy.

What is the General Purpose of Naloxone Hydrochloride?

The core purpose of Naloxone Hydrochloride is the rapid, temporary reversal of opioid effects, particularly the sudden suppression of breathing and loss of consciousness. Its robust mechanism involves immediate and powerful competitive inhibition at the central nervous system's opioid receptor sites, physically displacing the bound opioid molecules. This action swiftly restores the patient’s essential respiratory drive. A typical scenario involves using the medication to rapidly stabilize a patient who has become unresponsive and is exhibiting dangerously shallow breathing due to opioid intake, providing a critical window for subsequent advanced medical care.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Model List of Essential Medicines

What side effects are possible with Feng Du?

Possible Side Effects and Safety Information

The safety profile of Naloxone Hydrochloride is primarily defined by the consequence of its rapid action: the sudden displacement of opioids from receptors. In individuals who are physically dependent on opioids, this action can precipitate a severe, acute opioid withdrawal syndrome, which accounts for many of the documented adverse reactions across various physiological systems.

Documented Adverse Reactions

Adverse effects are formally classified by frequency in regulatory documents. Nausea is classified as a very common side effect. Other common reactions involve the cardiovascular and nervous systems, including tachycardia (increased heart rate), changes in blood pressure (hypotension or hypertension), headache, and vomiting.

Reactions are officially grouped into system-organ classes, affecting areas such as Cardiac disorders, Vascular disorders, and Nervous system disorders.

Serious Safety Considerations

While rare or very rare, regulatory documentation explicitly lists serious adverse reactions. These include severe events such as Cardiac Arrest, Ventricular Fibrillation, Pulmonary Edema, and Seizures (convulsions). The risk of these severe reactions has been noted, particularly in postoperative patients with pre-existing cardiovascular conditions.

Population-Specific Notes

The drug's label notes specific safety constraints for vulnerable populations. For opioid-dependent individuals, the medicine can cause the acute withdrawal syndrome mentioned above. Furthermore, there are documented risks for neonates exposed to opioids, where withdrawal symptoms may include severe reactions like convulsions.

Duration-Related Pattern

A critical safety consideration relates to the drug’s duration of action, which may be shorter than the effect of the opioid involved. This established pattern means the symptoms of respiratory depression can recur after initial improvement, a factor that defines the need for continued surveillance.

Overdose and Emergency Response

The regulatory profile for Naloxone Hydrochloride (Feng Du) is based on the acute signs of opioid toxicity and the required emergency response. Official labeling describes opioid overdose as an emergency manifested by severe respiratory and central nervous system (CNS) depression, presenting as critically slowed or stopped breathing, unresponsiveness, and pin-point pupils. Patients may also exhibit signs of inadequate oxygenation, such as pale or bluish skin discoloration (cyanosis).

Immediate emergency action is mandatory. Emergency medical assistance must be sought right away after the first dose is administered, and the patient must be kept under continued surveillance. This is mandated because the duration of action of many opioids exceeds that of Naloxone, creating a documented risk of recurrent respiratory depression. Additional doses may be required every two to three minutes until emergency personnel arrive.

The official profile also documents potential severe outcomes associated with abrupt reversal. These include serious cardiovascular events such as ventricular tachycardia, fibrillation, and hypertension, which are more frequently reported in postoperative patients. Furthermore, rapid reversal can precipitate acute opioid withdrawal syndrome in physically dependent individuals.

Therapeutic Uses of Feng Du

What Feng Du treats: Main Uses and Benefits

This medication is applied across therapeutic domains where additional symptomatic support is needed, primarily within emergency toxicology. The medicine is applied in addressing distressing manifestations of a known or suspected opioid overdose. Its primary indications include managing symptoms related to respiratory depression and subsequent loss of consciousness.

The agent is generally applied in conditions involving acute opioid overdose or toxicity, providing supportive relief when symptoms interfere with routine activities during the sudden onset of a crisis. It helps address symptom clusters centered around critically slowed or severely diminished breathing and unresponsiveness. The therapeutic benefit contributes to easing the overall symptom load related to systemic imbalance, supporting the patient during difficult episodes.

“The intervention is relevant when supportive symptom management is appropriate, especially when acute manifestations interfere with function.”

The medication is commonly used in clinical settings that involve acute or unstable symptom patterns within out-of-hospital settings. This supports general well-being during symptomatic phases for high-risk patient populations and their caregivers.

Quick Fact: Relief for Respiratory Depression
This medication is primarily relevant for easing symptoms related to systemic imbalance, specifically symptoms of severe physiological strain that characterizes acute opioid toxicity.

Regulatory References

  1. NIH MedlinePlus overview on Naloxone

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Feng Du — official regulatory information

Eligibility scope

Populations for whom use is allowed (as stated in label):

  • Adults and pediatric patients for the emergency treatment of known or suspected opioid overdose.
  • Neonates/newborns for the complete or partial reversal of opioid-induced respiratory depression.

Populations for whom use is contraindicated:

  • Patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained within the specific formulation.

Age-related eligibility rules:

  • Approved for both adults and pediatric patients for general emergency use.
  • Safety and efficacy of certain nasal spray formulations have not been established in children below 14 years.

Condition-specific eligibility rules:

  • Opioid-dependent individuals (including newborns) must be administered cautiously due to the risk of precipitating an acute opioid withdrawal syndrome.
  • Pre-existing cardiac disease requires caution due to the risk of adverse cardiovascular events upon abrupt opioid reversal.
  • Safety and effectiveness in patients with renal insufficiency/failure have not been established.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Use during pregnancy is permitted only when clinically required, as adequate human data are lacking.
  • Use during lactation is permitted with caution, as some regulators note no need to discontinue breast-feeding due to negligible oral absorption.

Connection to the overall eligibility profile

Regulatory documents establish that Naloxone Hydrochloride is widely accessible across most age groups for its emergency indication, placing the highest restriction, contraindication, only on individuals with documented hypersensitivity. For specific groups with unestablished safety profiles or documented physiological risks (such as opioid dependence), the eligibility profile mandates the medicine be administered cautiously.

What should I know about interactions with other medicines?

Feng Du Interactions with other medicines and products

This section describes only the specific interaction patterns, constraints, and restrictions formally documented in official government regulatory labels for Naloxone Hydrochloride (Feng Du).


Documented Pharmacodynamic and Physicochemical Interactions

Interaction Type Officially Documented Statement
Partial Opioid Agonists The reversal of effects caused by certain partial agonists, such as buprenorphine and pentazocine, may be incomplete or require larger or repeated doses due to their receptor binding characteristics.
Cardiovascular Risk Agents Co-administration with other medicinal products that carry a risk for adverse cardiovascular effects has been associated with an increased risk of serious cardiovascular events during abrupt opioid reversal.
Injectable Solution Mixing The injectable solution formulation must not be mixed with preparations containing bisulfite, metabisulfite, solutions having an alkaline pH, or certain high molecular weight anions due to physicochemical incompatibility.

Population-Specific Interaction Notes

  • Hepatic Impairment: Official regulatory data notes that plasma concentrations of Naloxone have been documented to be significantly higher in patients with liver cirrhosis (hepatic impairment) compared to those with normal liver function.
  • Patients with Pre-existing Cardiovascular Disorders: These patients have an increased susceptibility to serious adverse cardiovascular events during abrupt opioid reversal, especially when co-administered with other agents that affect the heart.

Mechanism of Action

The Naloxone Hydrochloride in Feng Du works by executing a precise, fast-acting competitive antagonism at opioid receptors within the central nervous system, which rapidly inhibits the cellular effects of opioid agonists.


High-Affinity Opioid Receptor Blockade

The drug functions as a pure competitive antagonist, engaging all three major opioid receptors (mu, kappa, and delta), but with the highest affinity for the mu -opioid receptor ( MOR). Its binding physically blocks the site, displacing the opioid agonist molecules that were previously activating the receptor.

Reversal of Inhibitory CNS Signal Transduction

By blocking the MOR, the drug immediately halts the opioid-agonist-induced Gi/ o-protein signaling cascade, which is responsible for neuronal hyperpolarization and reduced excitability in the central nervous system ( CNS). Reversing this inhibitory signal rapidly restores the functional activity of neurons in the CNS respiratory centers, re-establishing the body's sensitivity to carbon dioxide ( CO2) and enabling the spontaneous respiratory response.

⏳ Constraints Due to Mechanistic Kinetics

The drug’s mechanism is constrained by opioid agonists that possess extremely high receptor affinity and a slow dissociation rate (e.g., buprenorphine), requiring a greater antagonist concentration to achieve displacement. Furthermore, the drug has a short half-life, meaning its antagonistic effect can dissipate before longer-acting opioids are cleared, allowing the original suppression of physiological function to return.

Dosage and Administration Information

How Feng Du is Used: Official Administration Guidelines

Feng Du (Naloxone Hydrochloride) is intended for immediate administration in an emergency setting, with usage instructions established for its various formulations. The medicine is available as an injectable solution and as a ready-to-use nasal spray, dictating specific routes of administration.


Administration Routes and Dosing Regimens

Administration Route Standard Adult Initial Dose Range Frequency and Timing
Intravenous (IV), IM, or SC 0.4 mg to 2 mg (injection) Repeat every 2 to 3 minutes as needed.
Intranasal (IN) 4 mg or 8 mg (single spray) Repeat every 2 to 3 minutes as needed.

IV administration is generally preferred in emergency situations due to its rapid onset. The injectable formulation may also be diluted with 0.9% sodium chloride or 5% dextrose injection for continuous intravenous infusion in clinical settings.


Procedural and Population-Specific Rules

Administration devices, such as the nasal spray and auto-injector, are for single-use only and must not be reused. The nasal spray device must not be primed or tested prior to administration. If a second nasal dose is required, it should be administered in the alternate nostril using a new device.

For pediatric and neonatal patients, the initial dose for the injectable form is based on body weight, typically 0.01 mg/kg (IV, IM, or SC). The fixed-dose nasal spray is generally used in pediatric patients without dose adjustment.

Following the final dose, clinical protocols include keeping the patient under continued surveillance for a minimum of two hours, as the effects of certain opioids may outlast the action of Feng Du.

Recent Clinical Evidence

Feng Du: Recent Clinical Evidence


Evidence for Reversing Acute Opioid Effects

Research on Feng Du (Naloxone) primarily consists of studies focusing on its emergency use to address acute respiratory depression and impaired consciousness due to opioid exposure. Randomized Controlled Trials (RCTs) and real-world observational studies evaluate outcomes such as the time needed for a patient's breathing to return to an adequate rate and the level of responsiveness to improve. Findings describe patterns observed in these studies, where a rapid onset of physiological changes was observed following administration. This evidence base is essential for understanding the management of critical, short-term episodes. Ethical considerations inherent in life-threatening scenarios mean that evidence mainly compares different treatment strategies rather than testing the medication against a placebo. Uncertainty remains regarding the optimal dosing needed to reverse the effects of highly potent synthetic opioids, like fentanyl.


Administration Methods and Community Use

Comparative studies have explored various administration methods, primarily comparing the nasal spray form to the injectable solution. Research examined outcomes related to the speed of reversal, and studies describe patterns of variation in time-to-response between these two routes. Some research indicates that the injectable route may be associated with a lower likelihood of requiring additional doses compared to the nasal spray route, though both have been studied as effective for acute reversal.

The evidence base also includes large-scale public health and epidemiological research. Observational studies of community overdose prevention programs (OOPPs) that distribute Naloxone to laypersons suggest that trained bystanders are willing and able to administer the medication. These programs have been associated with changes in population-level outcomes, including reports of high survival rates following layperson administration in community settings.

Key Studies & References

  1. Preventing opioid overdose deaths with take-home naloxone
  2. Comparing the effectiveness and adverse events of intranasal and intramuscular naloxone formulations for opioid overdose reversal
  3. Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
  4. WHO Model List of Essential Medicines (relevant section on Antidotes)

Frequently Asked Questions (FAQ)

Common questions about Feng Du (FAQ)

Q: How does the mechanism of action for Feng Du compare to other similar treatments?

A: Feng Du is officially classified as a pure competitive opioid antagonist. Regulatory information notes that the reversal of effects caused by certain partial opioid agonists, like buprenorphine, may be incomplete or require larger or repeated doses due to how tightly those opioids bind to the receptors.

Q: Is Feng Du a common type of medicine?

A: Yes, the active ingredient in Feng Du (Naloxone) is included on the World Health Organization’s Model List of Essential Medicines. This indicates its recognized importance and inclusion for emergency use in rapidly countering the effects of opioids.

Q: What is the longest time people typically take Feng Du for?

A: Feng Du has a short duration of action and is intended only for immediate, emergency use. According to regulatory guidance, it is used to stabilize a patient during a critical episode until advanced medical care is available, and it is not prescribed or taken for long-term chronic treatment.

Q: Are there any common side effects from Feng Du that I should know about?

A: Official information states that very common side effects include nausea. Common side effects also include headache, vomiting, and cardiovascular reactions such as tachycardia (increased heart rate) or changes in blood pressure. For individuals who are physically dependent on opioids, the rapid action of the drug may trigger an acute opioid withdrawal syndrome.

Q: What happens if I accidentally miss a dose of Feng Du?

A: Feng Du is an emergency medicine administered only when known or suspected opioid effects need immediate reversal. It does not follow a daily or scheduled dosing regimen, so the concept of a 'missed dose' does not apply.

Q: Can older adults safely use Feng Du?

A: Regulatory documents indicate that studies have generally not demonstrated age-specific problems that would limit the usefulness of the medication in older adults. However, use requires caution for individuals with pre-existing cardiovascular conditions.

Q: Is Feng Du safe for teenagers or children?

A: Official labels state that Feng Du is indicated for use in adult and pediatric patients for emergency use. However, the safety and effectiveness of some nasal spray formulations have not been definitively established for children below 14 years of age.

Q: What should I do if I feel worse after starting Feng Du?

A: Because the effects of the opioid may return after the initial improvement, official guidelines require that emergency medical services (EMS) be contacted immediately after the first dose is given, and the patient be kept under continued surveillance, as symptoms can recur.

Q: How long does Feng Du stay in your system after you stop taking it?

A: The active ingredient in Feng Du (Naloxone) has a half-life of approximately 60 to 90 minutes. This means its antagonistic effect to block opioids can wear off before the effects of longer-acting opioids are fully cleared from the body, which is a key reason for the requirement of continued patient surveillance.

Q: Where can I find reliable information about Feng Du studies?

A: Reliable information regarding clinical trials and research evidence can be found in major government-sponsored resources. These include the Clinical Trials Registry (e.g., ClinicalTrials.gov) and the official regulatory documents (Prescribing Information or Summary of Product Characteristics) that were submitted for drug approval.

Q: Can Feng Du affect fertility or reproductive health?

A: Based on regulatory information, limited human data is available regarding the drug’s effect on fertility. However, animal studies have generally shown no impairment of fertility or reproduction. Its use in pregnant patients is permitted only when clinically required, as adequate human data is lacking.

Q: What should I do if I suspect an allergic reaction to Feng Du?

A: Feng Du is contraindicated for anyone known to be hypersensitive to Naloxone or any other ingredient in the formulation. In the event of signs consistent with a severe allergic reaction (such as difficulty breathing or swelling of the face, tongue, or throat), immediate emergency medical assistance is required.

Q: How long until the full therapeutic effect of Feng Du is usually reached?

A: For intravenous administration, the depressant effects of opioids are typically reversed within two minutes. The intranasal route may take slightly longer to reach the maximum concentration needed to initiate the reversal.

Q: Can I use Feng Du if I have pre-existing cardiovascular disorders?

A: Caution is required in patients with pre-existing cardiac disease. Regulatory documents note that these individuals face an increased risk of adverse cardiovascular events during the abrupt reversal of opioid effects. Serious reactions, including cardiac arrest, have been reported in this population.

Q: Does taking Feng Du affect blood pressure readings?

A: Yes, regulatory data indicates that the drug is associated with changes in blood pressure during the reversal process. Common adverse reactions include both hypotension (low blood pressure) and hypertension (high blood pressure).

Q: Is there a risk of dependency or withdrawal with Feng Du?

A: Feng Du is not associated with dependency on the drug itself. However, in any person who is physically dependent on opioids, its administration can precipitate a severe, acute opioid withdrawal syndrome because it rapidly displaces opioids from their receptors.

Q: What if I'm already taking multiple different medications, can I still use Feng Du?

A: Official prescribing information notes that co-administration with other medicinal products that carry a risk for adverse cardiovascular effects is associated with an increased risk of serious cardiovascular events during opioid reversal. The decision to administer the drug considers potential risks, especially when other medications that affect the heart are being used.

Q: What are the potential signs of a serious side effect from Feng Du?

A: While rare, serious adverse reactions have been officially documented. These include severe events such as cardiac arrest, ventricular fibrillation, pulmonary edema (fluid in the lungs), and seizures (convulsions).

Q: Can people with kidney issues take Feng Du?

A: Official labels note that the safety and effectiveness of the drug in patients with renal insufficiency or kidney failure have not been established. Regulatory documents indicate that the use of the drug in this population is based on the urgent clinical need for the emergency indication.

Q: Can people who are lactose intolerant take Feng Du?

A: Most injectable solution and nasal spray formulations are aqueous solutions and typically do not contain lactose. To confirm the presence or absence of specific excipients in any formulation, the complete product label contains that information.

Q: Can Feng Du be diluted for intravenous use?

A: The injectable formulation of the medicine may be diluted for use. Regulatory information confirms that it can be mixed with 0.9% sodium chloride or 5% dextrose injection for continuous intravenous infusion in clinical settings.

Q: Are there different brand names for the medicine known as Feng Du?

A: Yes, the active ingredient, Naloxone Hydrochloride, is available under various brand names. These different brands are approved by regulatory bodies for the same emergency use.

Q: Is there a generic version of Feng Du available?

A: Yes, regulatory bodies have approved generic versions of the drug. Both the injectable solution and the nasal spray are available in generic forms.

Q: Why do some people report not feeling any effect from Feng Du?

A: Regulatory sources explain that the reversal of respiratory depression caused by certain opioids, such as buprenorphine, may be incomplete. This is due to the opioid's specific receptor binding characteristics, which may require higher concentrations of Feng Du to achieve full reversal.

How should Feng Du be stored and disposed of?

The official labeling for Naloxone Hydrochloride (Feng Du) dictates specific storage and disposal requirements to ensure product stability and safety.

Storage Conditions

Requirement Regulatory Mandate
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container and protect from light; Do not freeze.
Safety Keep the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Naloxone must be managed according to local pharmaceutical waste regulations. The FDA recommends utilizing a drug take-back program when available. The product should not be disposed of in household trash or down the sink/toilet unless specifically authorized under official guidelines for household disposal of medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feng Du found in:

A-Z Index: